Skip to main content

M EVD 3 (Everolimus (for Oral Suspension) 3 mg)

Pill with imprint M EVD 3 is White, Round and has been identified as Everolimus (for Oral Suspension) 3 mg. It is supplied by Mylan Pharmaceuticals Inc.

Everolimus is used in the treatment of breast cancer; neuroendocrine carcinoma; organ transplant, rejection prophylaxis; pancreatic cancer; renal angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M EVD 3

Everolimus (for oral suspension) 3 mg M EVD 3

Everolimus (for Oral Suspension)

Imprint
M EVD 3
Strength
3 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
00378-0006
Inactive Ingredients
lactose anhydrous, butylated hydroxytoluene, croscarmellose sodium, crospovidone, hypromellose 2910, lactose monohydrate, magnesium stearate, mannitol, microcrystalline cellulose, silicon dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "M EVD 3"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.